DHL Supply Chain intends to further expand its capacities in the Life Sciences & Healthcare sector with the acquisition of SDS Rx. With the acquisition, DHL is also expanding its same-day and express delivery offerings for customers in the life sciences and healthcare sectors. “This acquisition is an important step in expanding our ability to provide precise and reliable care to patients. This underlines our commitment to providing reliable, patient-oriented solutions along the entire supply chain in the life sciences and healthcare sector,” says Hendrik Venter, Global CEO DHL Supply ChainDHL Supply Chain is committed to ensuring a smooth transition for customers and employees. As part of the acquisition, all employees will be transferred to DHL Supply Chain.